New Delhi: Bonatra has acquired women’s health and wellness company MyAva. Through this acquisition, Bonatra aims to expand its healthcare programs and become a one-stop platform for the management of chronic health conditions.
MyAva is a femtech startup that empowers women to manage chronic health conditions such as polycystic ovary syndrome (PCOS), thyroid disorders, insulin resistance, and more.
Bonatra is a doctor-led IoMT (Internet of Medical Things) start-up focused on treating and managing chronic diseases such as diabetes, Hypertension, fatty liver, PCOD, Obesity etc. It uses personalised treatment, which is arrived at after analysing multiple data points and health parameters using various easy-to-use IoMT devices.
Commenting on the acquisition, Rahul Kishore Singh, CEO and Co-Founder, Bonatra, said, “We are thrilled to welcome MyAva to join the Bonatra family. Acquiring MyAva enables us to expand our reach and deepen our expertise in women’s health, specifically for conditions like PCOS. We have been closely working with and interacting with the MyAva team and we believe that this will be a good strategic fit for Bonatra. Our mission is to empower people to take proactive measures to prevent, manage, and reverse chronic health conditions. This move will further strengthen our expertise in holistic healthcare solutions.”
Evelyn Immanuel, Founder and CEO, MyAva, said, “MyAva is elated to join Bonatra and further the vision of making chronic care management accessible to all women. We believe this further strengthens our combined commitment towards making femtech more inclusive and integrated.”
Very recently, Bonatra raised 5.5 crores in a Pre-Seed Round round led by ITI Growth Opportunities Fund with participation from marquee angel investors like Jitendra Jagadev, Founder, Nestaway and Helloworld, and Rajesh Yabaji, Founder, Blackbuck.
